Search research articles
Contact Us
Filters
Showing results (81-90 of 95) with videos related to
Page
of 10
Sort By:
European Journal of Pharmacology
|
March 5, 2026
Targeting the Keap1-Nrf2 Axis in COPD: Comparative analysis of electrophilic and peptide-based Nrf2 activators in airway and immune cells
Inés Roger, Cristina Estornut, Paula Montero, et al.
Respiratory Research
|
February 8, 2018
The JAK2 pathway is activated in idiopathic pulmonary fibrosis
Javier Milara, Gracia Hernandez, Beatriz Ballester, et al.
Vascular Pharmacology
|
April 10, 2024
Comparative analysis of antiproliferative and vasodilator effects of drugs for pulmonary hypertension: Extensive in vitro study in rats and human
Daniel Morales-Cano, Bianca Barreira, María Callejo, et al.
Current Eye Research
|
November 12, 2015
Evaluation of the Ocular Tolerance of Three Tacrolimus Topical Pharmaceutical Preparations by Bovine Corneal Opacity and Permeability Test
Alfonso Pastor-Clerigues, Adela Serrano, Javier Milara, et al.
International Journal of Molecular Sciences
|
December 11, 2022
N-acetylcysteine Reduces Inflammasome Activation Induced by SARS-CoV-2 Proteins In Vitro
Javier Milara, Fernando Martínez-Expósito, Paula Montero, et al.
Thorax
|
February 15, 2018
JAK2 mediates lung fibrosis, pulmonary vascular remodelling and hypertension in idiopathic pulmonary fibrosis: an experimental study
Javier Milara, Beatriz Ballester, Anselm Morell, et al.
Frontiers in Pharmacology
|
February 12, 2026
GTX-11 attenuates lung fibrosis, inflammation and vascular remodeling in preclinical models of lung fibrotic disease
Ana Montes-Worboys, Javier Milara, Consol Farrera, et al.
Anatolian Journal of Cardiology
|
March 24, 2016
mRNA PGC-1α levels in blood samples reliably correlates with its myocardial expression: study in patients undergoing cardiac surgery
Oscar Fabregat-Andres, Federico Paredes, María Monsalve, et al.
Plos One
|
January 25, 2018
Riociguat versus sildenafil on hypoxic pulmonary vasoconstriction and ventilation/perfusion matching
Virginia Chamorro, Daniel Morales-Cano, Javier Milara, et al.
Cardiovascular Research
|
September 19, 2019
A novel secreted-cAMP pathway inhibits pulmonary hypertension via a feed-forward mechanism
Carly Jones, Malik Bisserier, Carlos Bueno-Beti, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 95) with videos related to
Sort By:
Page
of 10
European Journal of Pharmacology
|
March 5, 2026
Targeting the Keap1-Nrf2 Axis in COPD: Comparative analysis of electrophilic and peptide-based Nrf2 activators in airway and immune cells
Inés Roger, Cristina Estornut, Paula Montero, et al.
Respiratory Research
|
February 8, 2018
The JAK2 pathway is activated in idiopathic pulmonary fibrosis
Javier Milara, Gracia Hernandez, Beatriz Ballester, et al.
Vascular Pharmacology
|
April 10, 2024
Comparative analysis of antiproliferative and vasodilator effects of drugs for pulmonary hypertension: Extensive in vitro study in rats and human
Daniel Morales-Cano, Bianca Barreira, María Callejo, et al.
Current Eye Research
|
November 12, 2015
Evaluation of the Ocular Tolerance of Three Tacrolimus Topical Pharmaceutical Preparations by Bovine Corneal Opacity and Permeability Test
Alfonso Pastor-Clerigues, Adela Serrano, Javier Milara, et al.
International Journal of Molecular Sciences
|
December 11, 2022
N-acetylcysteine Reduces Inflammasome Activation Induced by SARS-CoV-2 Proteins In Vitro
Javier Milara, Fernando Martínez-Expósito, Paula Montero, et al.
Thorax
|
February 15, 2018
JAK2 mediates lung fibrosis, pulmonary vascular remodelling and hypertension in idiopathic pulmonary fibrosis: an experimental study
Javier Milara, Beatriz Ballester, Anselm Morell, et al.
Frontiers in Pharmacology
|
February 12, 2026
GTX-11 attenuates lung fibrosis, inflammation and vascular remodeling in preclinical models of lung fibrotic disease
Ana Montes-Worboys, Javier Milara, Consol Farrera, et al.
Anatolian Journal of Cardiology
|
March 24, 2016
mRNA PGC-1α levels in blood samples reliably correlates with its myocardial expression: study in patients undergoing cardiac surgery
Oscar Fabregat-Andres, Federico Paredes, María Monsalve, et al.
Plos One
|
January 25, 2018
Riociguat versus sildenafil on hypoxic pulmonary vasoconstriction and ventilation/perfusion matching
Virginia Chamorro, Daniel Morales-Cano, Javier Milara, et al.
Cardiovascular Research
|
September 19, 2019
A novel secreted-cAMP pathway inhibits pulmonary hypertension via a feed-forward mechanism
Carly Jones, Malik Bisserier, Carlos Bueno-Beti, et al.
Page
of 10